Document:

exv4w9

 

Exhibit 4.9

	 	 	 
	Rights Certificate No.:

	 	Number of Rights:

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS DATED
FEBRUARY     , 2005 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE
PROSPECTUS ARE AVAILABLE UPON REQUEST FROM THE BANK OF NEW YORK, THE RIGHTS AGENT.

ORBIMAGE INC.

Incorporated under the laws of the State of Delaware

CUSIP NO.: 68555Y 12 7

SUBSCRIPTION RIGHTS CERTIFICATE

Evidencing Subscription Rights to Purchase Investment Units Consisting of

One Share of Common Stock and One Warrant to Purchase One Share of Common Stock of ORBIMAGE Inc.

Subscription Price: $10.00 per Unit

THE SUBSCRIPTION RIGHTS WILL EXPIRE IF NOT EXERCISED ON OR BEFORE 5:00 P.M., NEW YORK CITY TIME, ON
MARCH __, 2005, UNLESS EXTENDED BY THE COMPANY.

REGISTERED OWNER:

THIS CERTIFIES THAT the registered owner whose name is inscribed hereon is the owner of the number
of subscription rights (“Rights”) set forth above. Each whole Right entitles the holder thereof, or
its assigns, to subscribe for and purchase one investment unit (a “Unit”), consisting of one share
of common stock, with a par value of $0.01 per share, of ORBIMAGE Inc., a Delaware corporation,
(the “Common Stock”) and one warrant to purchase one share of Common Stock, at a subscription price
of $10.00 per Unit (the “Basic Subscription Privilege”), pursuant to a rights offering (the “Rights
Offering”), on the terms and subject to the conditions set forth in the Prospectus and the
“Instructions as to Use of ORBIMAGE Inc. Subscription Rights Certificates” accompanying this
Subscription Rights Certificate. If any Units available for purchase in the Rights Offering are not
purchased by other holders of Rights pursuant to the exercise of their Basic Subscription Privilege
(the “Excess Units”), any Rights holder that exercises its Basic Subscription Privilege in full may
subscribe for a number of Excess Units pursuant to the terms and conditions of the Rights Offering,
subject to proration, as described in the Prospectus (the “Over-Subscription Privilege”). The
Rights represented by this Subscription Rights Certificate may be exercised by completing Form 1
and any other appropriate forms on the reverse side hereof and by returning the full payment of the
subscription price for each Unit in accordance with the “Instructions as to Use of OBIMAGE Inc.
Subscription Rights Certificates” that accompanies this Subscription Rights Certificate. The Rights
evidenced by this Subscription Rights Certificate may also be transferred or sold by completing
Form 2 on the reverse side hereof in accordance with the “Instructions as to Use of ORBIMAGE Inc.
Subscription Rights Certificates” that accompanies this Subscription Rights Certificate.

Transferable on the books of ORBIMAGE Inc. in person or by duly authorized attorney upon surrender
of this Subscription Rights Certificate properly endorsed. This Subscription Rights Certificate is
not valid unless countersigned by the transfer agent and registered by the registrar.

Witness the seal of ORBIMAGE Inc. and the signatures of its duly authorized officers.

Dated: ________   __, 2005

	 	 	 
	 

	 	 
	Matthew M. O’Connell

Chief Executive Officer, President and Director

	 	William Lee Warren

Vice President, General Counsel and Secretary

COUNTERSIGNED AND REGISTERED:

THE BANK OF NEW YORK,

as Transfer Agent And Registrar

	 	 	 	 
	 	 
	By:  	 	 
	 	AUTHORIZED SIGNATURE 	 
	 	 	 
	 

 

 

DELIVERY OPTIONS FOR SUBSCRIPTION RIGHTS CERTIFICATE

	 	 	 
	For delivery by mail:
	 	By Hand or Overnight Delivery:
	 
	 	 
	The Bank of New York

Reorganization Services

ORBIMAGE Inc.

P.O. Box 11248

New York, NY 10286-1248
	 	The Bank of New York

Reorganization Services

101 Barclay Street

Receive and Deliver Window

Street Level

New York, NY 10286

Telephone: 800-507-9357

Delivery other than in the manner or to the addresses listed above

will not constitute valid delivery.

PLEASE PRINT ALL INFORMATION CLEARLY AND LEGIBLY.

FORM 1 — EXERCISE OF SUBSCRIPTION RIGHTS

To subscribe for Units pursuant to your Basic Subscription Privilege, please complete lines (a) and
(c) and sign under Form 4 below. To subscribe for Units pursuant to your Over-subscription
Privilege, please also complete line (b) and sign under Form 4 below.

(a) EXERCISE OF BASIC SUBSCRIPTION PRIVILEGE:

	 	 	 	 	 	 	 	 	 
	I apply for
	 	Units x	$	 	=	$	 
	
	 	 	 	 	 	 	 
	
	(No. of Units)	 		(Subscription Price)	 	 	(Payment)

(b) EXERCISE OF OVER-SUBSCRIPTION PRIVILEGE:

If you have exercised your Basic Subscription Privilege in full and wish to subscribe for
additional Units pursuant to your Over-Subscription Privilege:

	 	 	 	 	 	 	 	 	 
	I apply for
	 	Units x	$	 	=	$	 
	
	 	 	 	 	 	 	 
	
	(No. of Units)	 		(Subscription Price)	 	 	(Payment)

(c) Total Amount of Payment Enclosed = $ _________

METHOD OF PAYMENT (CHECK ONE):

	 	 	 
	o	 	Check or bank draft drawn on a U.S. bank, or postal, telegraphic or
express money order payable to “The Bank of New York, as
Subscription Agent.” Funds paid by an uncertified check may take at least
five business days to clear.

	 	 	 
	o	 	Wire transfer of immediately available funds directly to the account maintained by The Bank of New York, as Subscription Agent
for purposes of accepting subscriptions in this Rights Offering at

The Bank of New York

A/C # 8900060603

ABA # 021000018

REF: ORBIMAGE Inc. Subscription offer

FORM 2 — SALE OR TRANSFER TO DESIGNATED TRANSFEREE OR THROUGH BANK OR BROKER

To sell or transfer your subscription rights to another person, complete this Form and have your
signature guaranteed under Form 5. To sell your subscription rights through your bank or broker,
sign below under this Form 2 and have your signature guaranteed under Form 5, but leave the rest of
this Form 2 blank.

For value received ___of the subscription rights represented by this Subscription Rights
Certificate are assigned to:

	 	 	 	 
	 	 	 	 
	(Print Full Name of Assignee)
	 
	 

	 	 	 	 
	 	 	 	 
	(Print Full Address)
	 
	 

	 	 	 	 
	 	 	 	 
	Tax ID or Social Security No.
	 
	 

	 	 	 	 
	 	 	 	 
	Signature(s)	 
	 

IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this
Subscription Rights Certificate in every particular, without alteration or enlargement, or any
other change whatsoever.

 

 

FORM 3 — DELIVERY TO DIFFERENT ADDRESS

If you wish for the shares of Common Stock and warrants comprising the Units underlying your
subscription right or a certificate representing unexercised subscription rights to be delivered to
an address different from that shown on the face of this Subscription Rights Certificate, please
enter the alternate address below, sign under Form 4 and have your signature guaranteed under Form
5.

	 	 	 	 
	 
	 	 

	 	 	 	 
	 	 

	 	 	 	 
	 	 

FORM 4 — SIGNATURE

TO SUBSCRIBE: I acknowledge that I have received the Prospectus for this Rights Offering and I
hereby irrevocably subscribe for the number of Units indicated above on the terms and conditions
specified in the Prospectus.

	 	 	 	 
	 	 	 	 
	Signature(s)	 
	 

IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this
Subscription Rights Certificate in every particular, without alteration or enlargement, or any
other change whatsoever.

FORM 5 — SIGNATURE GUARANTEE

This form must be completed if you have completed any portion of Forms 2 or 3.

	 	 	 	 
	 	 
	Signature Guaranteed:	 	 
	 	(Name of Bank or Firm)	 
	 	 	 
	 

	 	 	 	 
	 	 
	By:  	 	 
	 	(Signature of Officer) 	 
	 	 	 
	 

IMPORTANT: The signature(s) should be guaranteed by an eligible guarantor institution (bank, stock
broker, savings & loan association or credit union) with membership in an approved signature
guarantee medallion program pursuant to Securities and Exchange Commission Rule 17Ad-15.

FOR INSTRUCTIONS ON THE USE OF ORBIMAGE INC. SUBSCRIPTION RIGHTS CERTIFICATES, CONSULT THE BANK OF
NEW YORK, THE RIGHTS AGENT, AT 800-507-9357.exv10w15

 

EXHIBIT 10.15

EMPLOYMENT-AT-WILL AGREEMENT

between

ORBIMAGE INC.

and

William Schuster

Effective as of December 6, 2004

To William Schuster:

1. Employment By The Company.

	 	1.1  	Subject to terms set forth herein, the Company agrees to continue to employ you as an
employee-at-will in the capacity of Chief Operating Officer. In this position, you will report to
the Company’s Chief Executive Officer, and be charged with supervising the general operations of
the Company’s business and insuring its smooth functioning, including in particular that the
Company satisfactorily meets ins obligations under the NextView Second Vendor program.

2. Compensation.

	 	2.1  	Salary. You will receive a base annual salary of $242,500, which will be paid
in accordance with standard Company policy (currently bi-weekly).
	 
	 	2.2  	Standard Company Benefits.
	 
	 	   	(a)  You will be entitled to all rights and benefits for which you are eligible under
the terms and conditions of the standard Company benefits and compensation practices
which may be in effect from time to time and provided by the Company to its
employees in senior executive positions (the “Company Benefits”).
	 
	 	   	(b)  The Company will pay up to $1,500 in premiums annually toward your company
provided life insurance coverage. Such coverage will be in the amount of $900,000,
subject to the continuing approval of the Company’s life insurance carrier.
	 
	 	2.3  	Severance. You will be entitled to the severance benefits (“Severance
Benefits”) described in Section 6 below, subject to the other terms and conditions
of this Agreement.
	 
	 	2.4  	Bonuses. You will be eligible to receive an annual bonus of 35% of your base
salary at target, subject to adjustment based upon the Company’s performance as
shown on Appendix A hereto. At least 25% of your annual bonus will be paid in
common stock of the Company and the remainder will be paid in cash. You may elect
to receive a higher proportion of your bonus in common stock. For the

 

	 	   	purpose of
calculating the number of shares of common stock to be issued, the value of such shares of common stock shall be the “Fair Market Value” of such shares as defined in
the Company’s 2003 Employee Stock Incentive Plan.
	 
	 	2.5  	Stock Grants

	 	2.5.1  	Restricted Stock. On the date that you commence your
employment, the Board of Directors of the Company will issue 10,000 shares of
restricted common stock of the Company to you pursuant to the Company’s 2003
Stock Incentive Plan. Of such shares (subject to changes set forth in a
separate Restricted Stock Agreement to be entered into between you and the
Company), 25% will vest on each December 31 beginning with December 31, 2005.
You will be granted “piggyback” registration rights for such shares on any
registration statement under the Securities Act of 1933, as amended,
registering common stock for sale filed by the Company, subject to the cutback
rights of the Company or the holders for whom such registration statement is
filed; provided that to the extent one or more registration statements are
filed before December 31, 2005, at least one shall include your shares if you
have so requested.
	 
	 	2.5.2  	Stock Options. On the date that you commence you employment,
you will be granted options to purchase 22,262 shares under the Company’s 2003
Employee Stock Incentive Plan, with a strike price of the fair market value on
the date of such grant. Of such options (subject to changes set forth in a
separate Option Agreement to be entered into between you and the Company), 25%
will vest on each December 31 beginning with December 31, 2005. You will be
granted “piggyback” registration rights for the shares underlying such options
on any registration statement under the Securities Act of 1933, as amended,
registering common stock for sale filed by the Company, subject to the cutback
rights of the Company or the holders for whom such registration statement is
filed; provided that to the extent one or more registration statements are
filed before December 31, 2005, at least one shall include your shares if you
have so requested.
	 
	 	2.5.3  	Additional Awards. You will be eligible for additional grants
of options and restricted stock under the Company’s 2003 Employee Stock
Incentive Plan and future plans as determined by the Compensation Committee of
the Company’s Board of Directors in its sole discretion.

3. Proprietary Information Obligations.

	 	3.1  	Confidentiality. You agree that all Confidential Information will be held in
complete confidence and that you will not, during your employment with the Company,
except in the performance of your duties to the Company, or at any time after the
termination of your employment with the Company, disclose to any person (other than the
Company or its affiliates), or use for your own account, without the prior written
consent of the Company, any Confidential Information. For purposes of this Agreement,
the term “Confidential Information” shall mean

2

 

	 	   	information relating to the
business and affairs of the Company or any of its affiliates that is of a confidential
nature.
	 
	 	3.2  	Ownership of Trade Secrets, etc.
	 
	 	   	(a)  All written materials, records and documents made by you or coming into your
possession during your employment with the Company concerning the business or
affairs of the Company or any of its affiliates shall be the sole property of the
Company and its affiliates. Upon the termination of your employment with the Company
or upon the earlier request of the Company during your employment with the Company,
you shall promptly deliver the same to the Company (or its designee).
	 
	 	   	(b)  You agree that any trade secret, invention, improvement, patent, patent
application or writing, and any program, system or novel technique (whether or not
capable of being trademarked, copyrighted or patented) conceived, developed or
otherwise obtained by you during your employment with the Company relating to the
business, property, methods, suppliers or customers of the Company or any of its
affiliates shall be the property of the Company and its affiliates; and you agree to
give the Company prompt written notice of your conception, invention, authorship,
development or acquisition of any such trade secret, invention, improvement, patent,
patent application or writing, and any program, system or novel technique and to
execute such instruments of transfer, assignment, conveyance or confirmation and
such other documents and to do all appropriate lawful acts as may be required by the
Company to transfer, assign, confirm and perfect in the Company all legally
protectible rights in any such trade secret, invention, improvement, patent, patent
application, writing, program, system or novel technique.
	 
	 	   	(c)  You represent and warrant that the execution and delivery by you of this
Agreement and the performance by you of your obligations hereunder will not, with or
without the giving of notice or the passage of time, (i) to the best of your
knowledge, violate any judgment, writ, injunction or order of any court, arbitrator
or governmental agency applicable to you or (ii) conflict with, result in the breach
of any provisions of or the termination of, or constitute default under, any
agreement to which you are a party or by which you are or may be bound,
including, but not limited to, any employment, confidentiality, non-competition or
non-solicitation agreement entered into between you and any previous employer. You
agree to indemnify and hold the Company harmless from and against any and all claims
for losses, liabilities, damages, costs and expenses which may arise or result from
the violation of any such judgment, writ, injunction or order or the breach of any
such agreement referred to in the immediately preceding sentence. You have
heretofore provided the Company with copies of any agreement referred to in (ii)
above to which you are bound.

3

 

	 	3.3  	Remedies. Your duties under this Section 3 shall survive termination of your
employment with the Company. You acknowledge that a remedy at law for any breach or
threatened breach by you of the provisions of this Section would be inadequate, and you
agree that the Company shall be entitled to injunctive relief in case of any such
breach or threatened breach.

4. Continuation Of Employment/Restrictive Covenant. During the term of your employment
and for a period of nine (9) months immediately following your termination, you shall not, without
first obtaining the prior written approval of the Company, directly or indirectly engage or prepare
to engage, in any activities in competition with the Company, or accept a management-level position
or establish a business relationship (such as management consulting) with a business or business
unit over 50% of whose gross annual revenues arise from the collection, processing or sale of
remote sensing imagery products or services (including data extraction, imagery analysis and
production of imagery related products) in direct competition with the Company or solicit, induce
or otherwise cause any customers of the Company to terminate or reduce their relationship with the
Company. Such approval by the Company shall not be unreasonably withheld.

5. Nonsolicitation. While employed by the Company, and for nine (9) months immediately
following your termination, you agree not to interfere with the business of the Company by
soliciting, attempting to solicit, inducing, or otherwise causing any employees of the Company to
terminate his or her employment.

6. Termination Of Employment.

(a) Either you or the Company may terminate your employment relationship at any time for any
reason whatsoever, or for no reason, with or without Cause or advance notice. This at-will
employment relationship cannot be changed except in a writing approved by the Board. If the
Company terminates your employment without Cause at any time, you will receive as Severance
Benefits: (i) regular bi-weekly payments equal to your usual base salary, less payroll
deductions and required withholdings, for nine (9) months (the “Severance Period”),
(ii) a payment of that portion of the bonus, if any, you are entitled to for the calendar
year based upon performance for such year pro-rated based upon the number of full months you
were employed in such year, payable at the time such amount would otherwise have been due
((i) and (ii) are sometimes collectively
referred to as the “Severance Payments”), and (iii) continuation of all group health
and life insurance benefits during the Severance Period, in exchange for the execution of a
release of all claims against the Company in form satisfactory to the Company. If you
resign voluntarily or if your employment is terminated for Cause, all compensation and
benefits will cease immediately, and you will receive no Severance Benefits. Your
“qualifying event” for purposes of Section 4980B of the Internal Revenue Code of 1986, as
amended (or any successor provision thereto), shall be your termination of employment.

4

 

For purposes of this Agreement, “Cause” shall mean misconduct, including: (i)
commission of any felony or any crime involving moral turpitude or dishonesty; (ii)
participation in a fraud or act of dishonesty against the Company; (iii) willful breach or
gross negligence of the Company’s policies; (iv) intentional damage to the Company’s
property; (v) material breach of this Agreement; (vi) your failure or refusal in a material
respect to follow the reasonable policies or directions of the Company as specified by the
Chief Executive Officer or Board of Directors after being provided with notice of such
failure and an opportunity to cure within seven (7) days of receipt of such notice; (vii)
any other act or omission which subjects the Company to substantial public disrespect,
scandal or ridicule or (viii) your failure to carry out the duties of your position after
being provided with notice of such failure and a reasonable opportunity to cure. Disability
shall not constitute Cause. For purposes of this Agreement, “Disability” shall mean
a disability that prevents you from substantially performing your duties under this
Agreement for a period of at least 45 consecutive days or 90 non-consecutive days within any
365-day period.

(b) In the event of death, the Company shall pay you any earned but unpaid salary at the
time of your death and, at the time such amount would otherwise have been due, a pro rata
portion of the bonus, if any, which may otherwise have been paid to you with respect to the
annual period in which the death occurs.

7. General Provisions.

     7.1 Employment At-Will. Please understand that your employment with the Company is “at will,”
meaning that you may terminate your employment with the Company at any time and for any reason
whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at
any time and for any reason, or for no reason, with or without Cause or advance notice. This
at-will relationship cannot be changed, nor may this Agreement be amended, except in a writing
signed by the President, Chief Executive Officer or Board of Directors of the Company.

     7.2 Notices. Any notices provided hereunder must be in writing and shall be deemed effective
upon the earlier of personal delivery (including by telecopy) or the third day after mailing by
first class mail, to the Company at its primary office location and to you at your address as
listed on the Company’s then current payroll records.

     7.3 Severability. Whenever possible, each provision of this Agreement will be interpreted in
such manner as to be effective and valid under applicable law, but if any provision of this
Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law
or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any
other provision or any other jurisdiction, but this Agreement will be reformed, construed and
enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never
been contained herein.

5

 

     7.4 Waiver. If either party should waive any breach of any provisions of this Agreement, he,
she or it shall not thereby be deemed to have waived any preceding or succeeding breach of the same
or any other provision of this Agreement.

     7.5 Complete Agreement. Please also understand that your acceptance of this Agreement should
not be based on any promises or representations other than those contained in this Agreement. Any
promises contrary to the terms specified in this Agreement are superceded by this Agreement. This
Agreement and any written option agreements between you and the Company constitute the entire
agreement between you and the Company and supercede any prior agreements between you and the
Company.

     7.6 Successors and Assigns. This Agreement is intended to bind and inure to the benefit of
and be enforceable by you and the Company, and each party’s respective successors, assigns, heirs,
executors and administrators, except that you may not assign any of your duties hereunder and
neither party may assign any of its rights hereunder without the written consent of the other
party, which shall not be withheld unreasonably. The Company shall require any successor (whether
direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or
substantially all of the business and/or assets of the Company to execute an agreement pursuant to
which the successor expressly assumes all of the liabilities and obligations of the Company
hereunder and agrees to perform this Agreement in the same manner and to the same extent the
Company would be required to perform if no such succession had taken place. If any successor
declines to offer you employment, refuses to assume this Agreement or fails to perform its
obligations hereunder, you will be deemed terminated without Cause and will be entitled to the
Severance Payments.

     7.7 Choice of Law. All questions concerning the construction, validity and interpretation of
this Agreement will be governed by the law of the Commonwealth of Virginia.

     7.8 Survival. The following provisions of this Agreement shall survive the termination of
your employment and the assignment of this Agreement by the Company to any successor in interest or
other assignee: Section 2; Section 3; Section 4 and Section 5.

     7.9 Injunctive Relief. You acknowledge that the restrictions set forth in Sections 3, 4 and 5
above are necessary to protect the Company’s confidential proprietary information and other
legitimate business interests and are reasonable in all respects, including duration, territory and
scope of activity restricted. You further acknowledge that the provisions of Sections 3, 4
and 5 hereof are essential to the Company, that the Company would not enter into this
Agreement if it did not include these provisions and that damages sustained by the Company as a
result of a breach of these provisions cannot be adequately remedied by damages, and You agree that
the Company, in addition to any other remedy it may have under this Agreement or at law, shall be
entitled to injunctive and other equitable relief to prevent or curtail any breach of Sections 3,
4, and 5 of this Agreement. You agree that the existence of any claim or cause of action by you
against the Company or its affiliates, whether predicated on this Agreement or otherwise, shall not
constitute a defense to the enforcement by the Company of any of the provisions of Sections 3, 4,
and 5 hereof.

6

 

     In Witness Whereof, the parties have executed this Agreement as of the day and year
first above written.

ORBIMAGE INC.

	 	 	 	 	 
	By:
	 	 	 	 
	

	 	 	 	 
	

	 	Name: Matthew M. O’Connell	 	 
	

	 	Title: Chief Executive Officer	 	 
	

	 	 	 	 
	EMPLOYEE:

	 
	 	 	 	 
	By:
	 	 	 	 
	

	 	 	 	 
	

	 	William Schuster	 	 

7

 

APPENDIX A

ANNUAL BONUS PERFORMANCE TARGETS

For the year ended December 31, 2005, the annual bonus will be paid as set forth on a pro rata
sliding scale. The bonus scale will be based on three factors: personal performance (1/3); the
Company’s EBITDA (1/3); and the execution of the NextView program on the schedule proposed to NGA
(1/3).

Personal Performance

Personal performance shall be determined by the Company’s CEO.

Company Value Measurement

1. If the Company’s EBITDA or such other value based measurement (the “Value Metric”) as is
determined by the Board of Directors for the CEO, COO and other senior executives is equal to the
target set forth in the business plan (the “Business Plan”) approved by the Board of
Directors, 100% of the Company value portion of the bonus will be paid.

2. If the Company’s Value Metric is below 70% of the target set forth in the Business Plan, 0% of
the Company value portion of the bonus will be paid.

3. If the Company’s Value Metric is equal to or greater than 125% of the target set forth in the
Business Plan, 137.5% of the Company value portion of the bonus will be paid.

The bonus will be pro rated between the high and the low.

Execution of the NextView program

	 	1.  	If the NextView program is executed according to the 2005 milestones set forth in the
Company’s contract with NGA, 100% of the NextView portion bonus factor will be paid.
	 
	 	2.  	If the NextView program attains the 2005 milestones at least three months ahead of
schedule, 135% of the NextView portion bonus factor will be paid.
	 
	 	3.  	If the NextView program attains the 2005 milestones one month or more behind schedule,
0% of the NextView portion bonus factor will be paid.

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]